These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


262 related items for PubMed ID: 10094221

  • 1. Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate.
    Kimata H.
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):293-5. PubMed ID: 10094221
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Usefulness of suplatast tosilate, a Th2 cytokine inhibitor based on the Th1/Th2 ratio for allergic disease in children: a retrospective study.
    Yoshihara S, Fukuda H, Arisaka O.
    Arzneimittelforschung; 2011 Mar; 61(7):421-4. PubMed ID: 21899211
    [Abstract] [Full Text] [Related]

  • 4. [The effect of suplatast tosilate on immunological parameters for the patients with atopic dermatitis].
    Suto H, Mitsuishi K, Hira K, Uchida T, Unno T, Ogawa H, Yoshiike T, Takamori K.
    Arerugi; 2000 Dec; 49(12):1163-72. PubMed ID: 11197882
    [Abstract] [Full Text] [Related]

  • 5. Early intervention with suplatast tosilate for prophylaxis of pediatric atopic asthma: a pilot study.
    Yoshihara S, Ono M, Yamada Y, Fukuda H, Abe T, Arisaka O.
    Pediatr Allergy Immunol; 2009 Aug; 20(5):486-92. PubMed ID: 19210644
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The effect of suplatast tosilate on the patients with atopic dermatitis--relationship between clinical symptoms and immunological parameters].
    Higashi N, Niimi Y, Aoki M, Fujimoto K, Suzuki K, Numano K, Kawana S.
    Arerugi; 2003 Nov; 52(11):1065-73. PubMed ID: 14685038
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Suplatast tosilate alters DC1/DC2 balance in peripheral blood in bronchial asthma.
    Yokomura K, Suda T, Matsuda H, Hashizume H, Asada K, Suzuki K, Chida K.
    J Asthma; 2005 Sep; 42(7):567-70. PubMed ID: 16169790
    [Abstract] [Full Text] [Related]

  • 10. Effect of suplatast tosilate on goblet cell metaplasia in patients with asthma.
    Hoshino M, Fujita Y, Saji J, Inoue T, Nakagawa T, Miyazawa T.
    Allergy; 2005 Nov; 60(11):1394-400. PubMed ID: 16197471
    [Abstract] [Full Text] [Related]

  • 11. [Cytokine production by peripheral blood mononuclear cells in bronchial asthma treated with suplatast tosilate].
    Yamasawa H, Oshikawa K, Sugiyama Y.
    Arerugi; 2001 Jun; 50(6):513-9. PubMed ID: 11517513
    [Abstract] [Full Text] [Related]

  • 12. [Inhibitory effect of suplatast tosilate on eosinophil migration].
    Kobayashi Y, Nagata M, Yamamoto H, Sakamoto Y.
    Arerugi; 2000 Jul; 49(7):600-3. PubMed ID: 10944827
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anti-inflammatory effect of suplatast tosilate on mild asthma.
    Sano Y, Miyamoto T, Makino S.
    Chest; 1997 Sep; 112(3):862-3. PubMed ID: 9315837
    [No Abstract] [Full Text] [Related]

  • 15. Suplatast tosilate prevents bleomycin-induced pulmonary fibrosis in mice.
    Furonaka M, Hattori N, Tanimoto T, Senoo T, Ishikawa N, Fujitaka K, Haruta Y, Yokoyama A, Kohno N.
    J Pharmacol Exp Ther; 2009 Jan; 328(1):55-61. PubMed ID: 18832650
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Suppression of the Th2 pathway by suplatast tosilate in patients with perennial nasal allergies.
    Furukido K, Takeno S, Ueda T, Hirakawa K, Yajin K.
    Am J Rhinol; 2002 Jan; 16(6):329-36. PubMed ID: 12512908
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.